December 7, 2024 - 21:01

Small businesses are gearing up for significant changes as President-elect Donald Trump has announced plans for hefty tariffs that could impact their operations. One of the key proposals includes imposing a 25% tax on imported goods, a move that many entrepreneurs fear could lead to increased costs for both businesses and consumers.
The proposed tariffs are aimed at protecting domestic industries, but small business owners worry that these measures could backfire. Many rely on imported materials and products to keep their prices competitive and maintain quality. The potential increase in costs could force some businesses to raise prices, which may deter customers and affect sales.
Small business advocates are voicing their concerns, emphasizing the need for a balanced approach that supports local businesses without imposing undue financial burdens. As the new administration prepares to take office, many small business owners are left wondering how these tariffs will affect their bottom line and the broader economy. The uncertainty surrounding these policies has created a climate of apprehension as they navigate the challenges ahead.
December 25, 2025 - 01:34
Celebrating Excellence: Highlights from the Best of Central Valley Business AwardsOn December 11, the Central Valley community gathered to celebrate the 12th annual Best of Central Valley Business awards, a prestigious event recognizing outstanding achievements across various...
December 24, 2025 - 04:09
Sapporo Holdings Divests Real Estate Business for $2.6 BillionIn a strategic shift, Sapporo Holdings has announced its decision to sell its real estate business to a consortium led by KKR for approximately $2.6 billion. This significant move underscores the...
December 23, 2025 - 19:43
Citius Pharmaceuticals Announces Fiscal Year 2025 Financial Results and Business DevelopmentsCitius Pharmaceuticals has released its financial results for the fiscal year 2025, showcasing significant developments in its business operations. The biopharmaceutical company, focused on...
December 23, 2025 - 05:52
enGene Announces Full Year 2025 Financial Results and Business DevelopmentsBOSTON & MONTREAL, December 22, 2025—enGene Holdings Inc., a clinical-stage company specializing in non-viral genetic medicines, has released its financial results for the year ending October 31,...